Summary & Overview
CPT 51798: Bladder Ultrasound for Post-Void Residual Measurement
CPT code 51798 represents the measurement of post-voiding residual urine and/or bladder capacity using a non-imaging ultrasound device. This urodynamic procedure is widely utilized in outpatient and office settings to assess bladder function, especially in patients with urinary retention or suspected bladder dysfunction. The code is recognized by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, ensuring broad coverage for providers and patients.
This publication provides a comprehensive overview of 51798, including payer coverage, clinical context, and relevant policy updates. Readers will gain insight into the procedure's role in urology, typical sites of service, and its importance in diagnosing and managing bladder conditions. The summary also highlights associated billing practices, such as common modifiers and related CPT codes, as well as the clinical diagnoses most frequently linked to this service. Benchmarks and regulatory considerations are discussed to inform stakeholders about current trends and requirements for accurate reporting and reimbursement. The content is designed to support healthcare professionals, administrators, and policy analysts in understanding the national landscape for this urodynamic procedure.
CPT Code Overview
CPT code 51798 is used to report the measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging. This procedure is a urodynamic assessment that utilizes a portable bladder scanner to evaluate bladder function without the need for imaging. It is commonly performed in the office setting or other outpatient environments, aligning with LCD guidelines for portable scanner usage. The service is essential for monitoring urinary retention and bladder health, particularly in patients with suspected or known bladder dysfunction.
Clinical & Coding Specifications
Clinical Context
A patient presents to a urology clinic with symptoms such as urinary retention, difficulty voiding, or suspected bladder dysfunction. The provider suspects conditions like uninhibited neuropathic bladder, flaccid neuropathic bladder, neuromuscular dysfunction of the bladder, or bladder-neck obstruction. To assess bladder function, the provider performs a urodynamic procedure using a portable bladder scanner to measure post-void residual urine volume and/or bladder capacity. This is a non-imaging ultrasound procedure typically performed in an office or outpatient setting. The results help guide further management of the patient's urinary symptoms.
Coding Specifications
-
Modifiers:
- Modifier
26: Used when reporting only the professional component of the service (interpretation of the results). - Modifier
TC: Used when reporting only the technical component (performance of the procedure and use of equipment).
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
208800000X | Urology Physician |
2088P0231X | Pediatric Urology Physician |
2088F0040X | Female Pelvic Medicine and Reconstructive Surgery Physician |
These specialties are typically involved in performing and interpreting urodynamic procedures such as bladder ultrasound for post-void residual measurement.
Related Diagnoses
-
N31.0: Uninhibited neuropathic bladder, not elsewhere classified- Relevant for patients with involuntary bladder contractions leading to urinary symptoms, often requiring post-void residual measurement.
-
N31.2: Flaccid neuropathic bladder, not elsewhere classified- Indicates a bladder with reduced muscle tone, resulting in incomplete emptying and the need for residual urine assessment.
-
N31.9: Neuromuscular dysfunction of bladder, unspecified- Used when the specific type of bladder dysfunction is unclear, but urodynamic evaluation is necessary.
-
N32.0: Bladder-neck obstruction- Obstruction at the bladder neck can cause urinary retention, making post-void residual measurement clinically relevant.
Related CPT Codes
-
51792: Measures electrical activity in the anal or urethral sphincter muscles (urodynamic procedure on the bladder).- This code is used for assessing sphincter muscle function, often performed alongside bladder ultrasound to provide a comprehensive urodynamic evaluation.
-
51797: Urodynamic procedure on the bladder (neighboring code in same section).- This code represents another urodynamic test related to bladder function and may be used in conjunction with or as an alternative to
51798depending on the clinical scenario.
- This code represents another urodynamic test related to bladder function and may be used in conjunction with or as an alternative to
These codes are commonly used together in a urodynamic study to evaluate different aspects of bladder and sphincter function.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT code 51798 is $13.23, which is notably lower than the average commercial mean rate represented by BUCA at $20.22. Commercial payers such as Cigna and UnitedHealth Group offer higher mean rates, with Cigna reaching $23.28 and UnitedHealth Group at $21.53, while Blue Cross Blue Shield and Aetna are closer to the BUCA average.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare exhibits the tightest range at $2.00, indicating minimal variation in rates. In contrast, Cigna has the widest dispersion at $19.00, reflecting significant variability in reimbursement. Other commercial payers show moderate ranges, with Blue Cross Blue Shield at $12.00 and UnitedHealth Group at $12.00.
The table and chart below present the full breakdown of national benchmarks for CPT code 51798 across major payers.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska exhibits a notable spread in reimbursement rates for CPT code 51798, with Blue Cross Blue Shield showing the widest range between the 25th and 75th percentiles ($48.25 minus $36.41 = $11.84). Aetna, UnitedHealth Group, and Cigna display narrower spreads, indicating more consistent rates across providers. The mean rates for most commercial payers in Alaska are substantially higher than their respective national averages, especially for Aetna and Blue Cross Blue Shield.
The table and chart below present the full breakdown of payer-specific reimbursement rates in Alaska, highlighting the differences in mean, median, and percentile values for CPT code 51798. This allows for a clear comparison of how each payer positions itself within the state market.
Key Insights for Alaska
- Aetna is the highest paying payer for CPT 51798 in Alaska, with a mean rate of $46.03, while Medicare is the lowest at $12.61.
- Most commercial payers in Alaska reimburse at rates significantly above their national averages, with Aetna and Blue Cross Blue Shield showing the largest deviations.
- The rate spread is widest for Blue Cross Blue Shield, indicating substantial variability in reimbursement across providers.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.